Home / IMMUNITYBIO, INC. (IBRX)
Stock Analysis
IMMUNITYBIO, INC. (IBRX)
7.13 +0.42%
Updated: 2026-06-16 10:39 UTC
Technology-style analysis layer: price structure, momentum, key levels and business quality in one view.
WOI Investment Thesis
Mixed
Momentum: Neutral
Range: 54% of 52W range
Bull7.46
Base7.46
Bear5.84
Key Levels
Resistance7.46
Support5.84
InvalidationBelow 5.84
Upside Target—
Price Chart
IBRX · Interactive chart workspace
Open Full Workspace
Analyst Narrative
IMMUNITYBIO, INC. (IBRX) finished the session at 7.13 (+0.42%). Medium-term tone has softened, but price remains above MA200. Momentum remains weak (-10.54%); 52W position: 53% of range; and Volatility: ATR14 5.50%. RSI(14) stands around 44.8, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet.
🔺
Setup: Pattern Triangle compression remains the main pattern under review.
🎯
Key levels: The most important nearby levels are support at 5.84 and resistance at 7.46.
🚀
Trigger: Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup.
Technical Setup
🔺 Technical Setup
Pattern
Triangle Compression / SYM / DOWN
State
Forming
Breakout Watch
Downtrend line not broken yet · score 6
Watch Level
7.55
Compression
15%
RSI(14)
44.8
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 5.85 and resistance around 7.46. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Business Lens
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Strong 💰 Profit: Negative 💵 Cash: Mixed 🛡 Balance: Manageable
• Quarterly revenue growth remains strong and still points upward.
• Quarterly profitability remains weak, with net margin below zero.
💵 Revenue
44.21M
📈 Net Income
-632.80M
🧮 EPS (Basic)
-0.62
🏢 Company
IMMUNITYBIO, INC.
🏷 Sector
Healthcare
🧩 Industry
Biotech
Compare with related stocks
Same sector and industry ideas for deeper research
Amgen (AMGN) technical analysisAxsome Therapeutics (AXSM) technical analysisBeam Therapeutics (BEAM) technical analysisCRISPR Therapeutics AG (CRSP) technical analysisAmicus Therapeutics (FOLD) technical analysisImmunome (IMNM) technical analysisAbbVie (ABBV) technical analysis
Note: This is an algorithmic technical snapshot, not financial advice.